2221P Precision oncology in advanced thyroid carcinomas: Impact of molecular tests on patients’ outcomes

• DOI: 10.1016/j.annonc.2023.09.1000
• Publication Date: 2023-10-20T11:56:11Z
• Authors: E. Colombo; S. Cavalieri; E. Tamborini; F. Perrone; B. Paolini; A. Ottini; F. Caspani; S. Buriolla; C. Bergamini; S. Alfieri; C. Resteghini; I. Nuzzolese; A. Vingiani; M. Duca; L. Agnelli; G. Pruneri; L.D. Locati; L.F.L. Licitra
• Keywords: Cabozantinib; Tolerability; Refractory (planetary science); Progression-free survival; Targeted Therapy